Dr Helen Aspasia Petousis-Harris

BSc, PGDipSc (Distinction), PhD

Biography

I am a Vaccinologist, Senior Lecturer in the Department of General Practice and Primary Health Care and the Director of Research at the Immunisation Advisory Centre. For the past nineteen years I have been involved in immunisation-related research in New Zealand including clinical, social science, epidemiological and health systems. My main research areas are vaccine safety and vaccine effectiveness. I am a media spokesperson on vaccines and vaccination and have a role within the Immunisation Advisory Centre to provide scientifically based information on vaccines and vaccination to inform research strategy and current national practice and communicate the science of vaccination to the public. I am involved in undergraduate and postgraduate teaching on vaccines and vaccination and immunisation related research.

My research interests include vaccine effectiveness and vaccine safety. I am a member of the World Health Organization Global Advisory Committee on Vaccine Safety (GACVS) and the International Brighton Collaboration Science Board.

Research | Current

Research interests

  • Vaccines and Vaccination
  • Safety of Vaccines
  • Effectiveness of Vaccines
  • Vaccine Communication

 

Postgraduate supervision

Supervision of Research Students.

Doctoral Students

Mr Adrian Ludlam. The HPreV Study: Human papillomavirus (HPV) infection, awareness, and vaccine acceptability among high-risk New Zealand males.

Ms Jazmin Duque. The Association Between Febrile Illness During Pregnancy and Adverse Outcomes Affecting the Offspring

Ms Hannah Chisholm. Understanding pertussis vaccine failure

 

Responsibilities

Director of Immunisation Research and Vaccinology

Areas of expertise

  • General Vaccinology - vaccines and vaccination
  • Vaccine Preventable Diseases - in particular pertussis, human papillomavirus, pneumococcal disease, meningococcal disease
  • Vaccines - acellular pertussis, conjugate pneumococcal vaccines, OMV vaccines, recombinant vaccines
  • Vaccine Safety
  • Vaccine Efficacy and Effectiveness
  • Adressing Vaccine Mythology and Misconceptions

Committees/Professional groups/Services

Member of the World Health Organization Global Advisory Committee on Vaccine Safety 

Member of the International Brighton Collaboration Science Board

Convenor of the NZ Safety Expert Advisory Group

Member Australian AusVaxSafety Governance Board

Professional Member of The Royal Society of New Zealand

Member, International Society for Vaccines

Member Professional Advisory Board of the New Zealand HPV Project

Professional Member Royal Society of New Zealand (MRSNZ)

Selected publications and creative works (Research Outputs)

  • Petousis-Harris, H. (2018). Impact of meningococcal group B OMV vaccines, beyond their brief. Human Vaccines & Immunotherapeutics, 14 (5), 1058-1063. 10.1080/21645515.2017.1381810
  • Petousis-Harris, H., Paynter, J., Morgan, J., Saxton, P., McArdle, B., Goodyear-Smith, F., & Black, S. (2017). Effectiveness of a group B outer membrane vesicle meningococcal vaccine against gonorrhoea in New Zealand: A retrospective case-control study. The Lancet, 390 (10102), 1603-1610. 10.1016/s0140-6736(17)31449-6
    Other University of Auckland co-authors: Peter Saxton, Janine Paynter, Barbara McArdle, Felicity Goodyear-Smith
  • Petousis-Harris, H., Paynter, J., Morgan, J., Saxton, P., Goodyear-Smith, F., McArdle, B., & Black, S. (2017). Effectiveness of a group B OMV meningococcal vaccine against gonorrhoea – the New Zealand experience. Paper presented at IV International Congress of Pharmacology of Vaccines (Vaccipharma) 2017, Varadero Beach, Cuba. 25 June - 29 June 2017. Related URL.
    Other University of Auckland co-authors: Peter Saxton, Felicity Goodyear-Smith, Barbara McArdle
  • Radke, S., Petousis-Harris, H., Watson, D., Gentles, D., & Turner, N. (2017). Age-specific effectiveness following each dose of acellular pertussis vaccine among infants and children in New Zealand. Vaccine, 35 (1), 177-183. 10.1016/j.vaccine.2016.11.004
    URL: http://hdl.handle.net/2292/32180
    Other University of Auckland co-authors: Nikki Turner
  • Petousis-Harris, H., Paynter, J., Morgan, J., Saxton, P., Sherwood, J., McArdle, B., ... Black, S. (2016). EFFECTIVENESS OF A GROUP B OMV MENINGOCOCCAL VACCINE ON GONORRHOEA IN NEW ZEALAND - A CASE CONTROL STUDY. Paper presented at Sexually Transmitted Diseases (STD) Prevention Conference, Atlanta, GA. 20 September - 23 September 2016. SEXUALLY TRANSMITTED DISEASES. (pp. 1).
    Other University of Auckland co-authors: Peter Saxton, Felicity Goodyear-Smith, Janine Paynter
  • Petousis-Harris, H., Walls, T., Watson, D., Paynter, J., Graham, P., & Turner, N. (2016). Safety of Tdap vaccine in pregnant women: An observational study. BMJ Open, 6 (4)10.1136/bmjopen-2015-010911
    URL: http://hdl.handle.net/2292/32186
    Other University of Auckland co-authors: Nikki Turner, Janine Paynter
  • Petousis-Harris, H., & Paynter, J. (2016). Cherry picked case reports are not scientific evidence in the face of large clinical and epidemiological studies. Clinical rheumatology, 35 (3), 837-838. 10.1007/s10067-016-3189-x
    URL: http://hdl.handle.net/2292/32359
    Other University of Auckland co-authors: Janine Paynter
  • Petousis-Harris, H. (2016). Proposed HPV vaccination syndrome is unsubstantiated. Clinical Rheumatology, 35 (3), 833-834. 10.1007/s10067-015-3090-z
    URL: http://hdl.handle.net/2292/32745

Identifiers

Contact details

Primary office location

TAMAKI BUILDING 731 - Bldg 731
Level 3, Room 304
TAMAKI CAMPUS GATE 1 261 MORRIN RD
ST JOHNS
AUCKLAND 1072
New Zealand

Social links

Web links